North America accounted for the largest share of the metabolomics market.

North America accounted for the largest share of the metabolomics market in 2019.

In 2020, Agilent and Thermo Fisher extended their agreement to enhance the compatibility of Thermo Fisher’s analytical systems with Agilent’s OpenLAb Chromatography Data System.

The global Metabolomics Technology Market size is projected to reach USD 4.1 billion by 2025, at a CAGR of 13.4% between 2020 and 2025.

North America accounted for the largest share of the metabolomics market in 2019.

North America accounted for the largest share of the metabolomics market in 2019

North America accounted for the largest share of the metabolomics market in 2019.

Separation tools accounted for the largest share in the metabolomics market in 2019

Separation tools accounted for the largest share in the metabolomics market in 2019.

The biomarker discovery segment accounted for the largest share of the metabolomics market

The biomarker discovery segment accounted for the largest share of the metabolomics market

Increasing demand for personalized medicines and ongoing innovations in metabolomics instruments provides growth opportunities to metabolomics market

Growth Driver: Availability of government and private funding for metabolomics research

Growth Driver: Availability of government and private funding for metabolomics research

North America dominated the Metabolomics Technology Market

North America dominated the Metabolomics Teschnology Market

North America dominated the Metabolomics Market.

North America dominated the Metabolomics Technology Market

APAC to grow at the highest CAGR during the forecast period.

Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) - Forecast

The Global Metabolomics Market is expected to reach USD 2,386.4 million by 2021 from USD 1,209.4 million in 2016, at a CAGR of 14.6% during the forecast period.

The metabolomics market has witnessed significant growth primarily due to the increasing need for accurate diagnosis of diseases, rising demand for personalized medicine, and emergence of advanced technologies.

The Global Metabolomics Market is expected to grow at a CAGR of 14.6% during the forecast period to reach USD 2.39 Billion.

Metabolomics is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and s

The global metabolomics market is expected to reach USD 2,386.4 million, at a CAGR of 14.6%

The Metabolomics Market has witnessed significant growth due to an increasing need for accurate diagnosis of diseases, and the advanced technologies.

[286 Pages Report] The global Metabolomics Market is expected to reach USD 2,386.4 million by 2021 from USD 1,209.4 million in 2016, at a CAGR of 14.6% during the forecast period.

[286 Pages Report] Metabolomics is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biolo

The report "Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) - Forec